⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Ramadan — the ninth month of the Islamic lunar calendar — is observed by more than 200 million Muslims in India and across South Asia. For the approximately 30 days of Ramadan, observant Muslims fast from Fajr (pre-dawn) to Maghrib (sunset), refraining from all food, water, and oral medications during daylight hours.
For Indian Muslims on GLP-1 medications like Ozempic (semaglutide), Mounjaro (tirzepatide), Wegovy, or Victoza, Ramadan presents a unique and manageable — but important — medical challenge.
Consult your healthcare provider before starting any medication, and consult them well in advance of Ramadan to plan medication management for the fasting month.
Unlike single-day fasts such as Karva Chauth or Navratri, Ramadan involves:
This sustained, daily pattern makes Ramadan significantly more complex than a single-day fast for GLP-1 users.
In India, approximately 200 million Muslims observe Ramadan. Roza timings vary by region:
| City | Approximate Roza Duration (Summer Ramadan) |
|---|---|
| Delhi | 15–16 hours |
| Mumbai | 14–15 hours |
| Kolkata | 15–16 hours |
| Hyderabad | 14–15 hours |
| Chennai | 14–15 hours |
| Srinagar | 17–18 hours |
| Kochi | 13–14 hours |
Summer Ramadan (which India experiences cyclically) is more dehydrating and physically demanding than winter Ramadan.
This is the primary concern, especially for diabetic GLP-1 users who also take:
GLP-1 medications themselves have a very low independent risk of hypoglycaemia. However, when combined with the above drug classes plus prolonged fasting, blood sugar can drop dangerously.
Key hypoglycaemia warning signs: Sweating, shakiness, palpitations, confusion, fainting.
Islamic ruling on hypoglycaemia: Most Islamic scholars and the Islamic Fiqh Academy agree that breaking the fast (Roza) is obligatory (wajib) when a person's health is at genuine risk. Treating hypoglycaemia always takes precedence.
GLP-1 medications reduce thirst perception in some users. Combined with 14–17 hours without water, dehydration risk is real — particularly in summer.
GLP-1 peak side effects (nausea, vomiting) must be carefully timed away from the fasting window. Taking a weekly injection and then spending the subsequent 24–48 hours fasting without food or water creates significant discomfort.
Most GLP-1 medications are given subcutaneously (by injection) and are not classified as "oral intake" — they do not break the fast according to most Islamic scholars. However, consult your own religious authority for confirmation.
The consensus position among most Islamic scholars (including those at Dar ul-Uloom Deoband, prominent institutions in India) is:
Practical implication: Weekly GLP-1 injections (Ozempic, Wegovy, Mounjaro) can be given at any time during Ramadan without breaking the fast. Daily injections (Victoza, Saxenda) should ideally be timed during Sehri or Iftar.
Always confirm with your own religious scholar or imam if you have doubts.
Schedule an appointment with your diabetologist or endocrinologist at least 4–6 weeks before Ramadan begins. Discuss:
The IDF-DAR (International Diabetes Federation – Diabetes and Ramadan) guidelines provide a risk stratification framework that many Indian endocrinologists use. Ask your doctor about your risk category.
Sehri is the most important meal of the day for GLP-1 users during Ramadan. It must sustain blood sugar for 14–17 hours.
Option 1 (North Indian):
Option 2 (South Indian):
Option 3 (High-Protein Focus):
Avoid at Sehri:
Traditional Iftar involves dates, water, then a larger meal. This sequencing is actually medically sound and aligns well with GLP-1 management.
Step 1: Dates and Water (immediately at Maghrib)
Step 2: Light Iftar (15–20 minutes later)
Step 3: Main Meal (30–60 minutes after Iftar begins)
GLP-1 and Iftar Challenges:
The 2-hour Iftar-to-Taraweeh-to-sleep window is your primary hydration opportunity. Target:
For weekly GLP-1 injections (Ozempic, Mounjaro, Wegovy), the goal is to avoid peak side effects (nausea, fatigue) during fasting hours.
Recommended approach:
If you are diabetic, your doctor will give you specific targets. General guidance:
| Blood Sugar Reading | Action |
|---|---|
| Below 70 mg/dL | Break the fast immediately, treat hypoglycaemia |
| 70–90 mg/dL | High risk; consider breaking fast with food |
| 90–180 mg/dL | Safe range during Ramadan fast |
| Above 300 mg/dL | Break fast; risk of DKA (diabetic ketoacidosis) |
Check blood sugar at least 3 times during the fast:
Islamic scholars' ruling: Using a glucometer (blood glucose monitor) does not break the Roza — blood sampling from a finger does not constitute intake.
Q: Does my weekly Ozempic injection break my Roza?
A: According to most Islamic scholars, subcutaneous (under-skin) injections that provide no nutrition do not break the fast. However, confirm with your imam or religious scholar for your specific tradition.
Q: Should I stop my GLP-1 medication during Ramadan?
A: No — unless your doctor specifically advises it. GLP-1 medications are generally safe to continue during Ramadan, and stopping for a month disrupts your treatment progress.
Q: I am taking Mounjaro and insulin. Is fasting safe?
A: This requires specific medical guidance. The combination significantly increases hypoglycaemia risk during fasting. See your endocrinologist before Ramadan — your insulin dose will likely need to be adjusted.
Q: I vomited during the fast due to GLP-1 nausea. Does this break my Roza?
A: Involuntary vomiting does not break the Roza according to most scholars. However, if you feel severely ill, breaking the fast for health reasons is permissible and may be required.
Ramadan is a month of spiritual growth, community, and reflection — with careful medical planning, GLP-1 users can observe it fully and safely.
Always consult your healthcare provider before starting any medication and well before Ramadan begins to plan safe fasting management.
